Polyphyllin VI is a natural product that induces pyroptosis through the ROS/NF-κB/NLRP3/GSDMD signaling axis in NSCLC, suggesting that polyphyllin VI is a potential therapeutic option for NSCLC patients (73). This evidence concerns the gene NLRP3 and non-small cell lung carcinoma.